How Uncertainty in Patentability Will Impact Modality Selection for Biotherapeutics

PDF

Professionals

Sheraton Boston

Sept. 18, 2020

John Conley will present at the Cambridge Healthtech Institute's Modality Selection for Next-Gen Biotherapeutics conference as part of the Discovery on Target event. His session will discuss how uncertainty in patentability will impact modality selection for biotherapeutics. For more information or to register, visit Discovery on Target.

Main Menu